Style
CoreTurnover
Orientation
Concentrated trader| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Celldex Therapeutics Inc New(CLDX) | 5,322,908 | $198.1M | 10.95% |
| 2 | Syndax Pharmaceuticals Inc(SNDX) | 8,050,959 | $176.0M | 9.73% |
| 3 | Vaxcyte Inc(PCVX) | 2,922,335 | $169.9M | 9.39% |
| 4 | Cogent Biosciences Inc(COGT) | 3,667,097 | $141.9M | 7.84% |
| 5 | Vera Therapeutics Inc(VERA) | 2,890,059 | $124.0M | 6.85% |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 95.25% | 92.78% | -2.47% |
| Unclassified | 4.75% | 7.22% | +2.47% |
Quarter-over-quarter weight changes by market cap
| 6 |
| Viridian Therapeutics Inc(VRDN) |
| 6,453,877 |
| $118.6M |
| 6.55% |
| 7 | Travere Therapeutics Inc(TVTX) | 2,000,000 | $113.6M | 6.28% |
| 8 | Beam Therapeutics Inc(BEAM) | 2,840,792 | $97.5M | 5.39% |
| 9 | Urogen Pharma LTD(URGN) | 2,434,207 | $89.6M | 4.95% |
| 10 | Legend Biotech Corp(LEGN) | 3,001,205 | $86.7M | 4.79% |
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Mid Cap | 60.42% | 58.22% | -2.2% |
| Small Cap | 32.66% | 31% | -1.66% |
| Unclassified | 4.75% | 7.22% | +2.47% |
| Micro Cap | 2.18% | 2.01% | -0.17% |
| Large Cap | 0% | 1.56% | +1.56% |
Quarter-over-quarter position changes